Health / Medical Topics

    Immunomodulator OHR/AVR118

    A broad-spectrum peptide nucleic acid formulation comprised of breakdown products of casein, peptone, RNA and serum albumin, with potential anti-inflammatory, immunomodulatory, anti-anorectic and anti-cachexia activities. AVR118 mainly contains two peptides, peptide A and peptide B, in approximately a 1:1 ratio: peptide A (31 a. a.) is derived from bovine casein; peptide B (21 a. a.) is covalently linked via phosphodiester bond to a diadenosine unit. In addition, AVR118 contains nucleosides, nucleoside diphosphates and nucleoside monophosphates. Upon subcutaneous injection of AVR118, this agent affects the synthesis of many pro-inflammatory chemokines and cytokines, especially monocyte chemotactic protein-1 (MCP-1), interleukin (IL)-8, IL-1 beta, IL-6, and tumor necrosis factor-alpha (TNF-alpha). In particular, AVR118 stimulates macrophages to produce these mediators while in highly activated macrophages this agent inhibits their synthesis. This way, AVR118 may prevent the excessive release of cytokines seen during chemotherapy. Controlling the release of pro-inflammatory mediators may ultimately improve appetite and mood, increase strength and weight gain, and decrease fatigue. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    Change in the body's immune system, caused by agents that activate or suppress its function.
    A substance that stimulates or suppresses the immune system and may help the body fight cancer, infection, or other diseases. Specific…
    A separation column that when placed in proximity to a magnet creates a high gradient magnetic field strong enough to retain cells…
    This term is used as a form filler when there is no appropriate Immunology term available.
    Laboratory test involving interaction of antigens with specific antibodies.
    The study of the body's immune system.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact